For the Inventor, By the Inventor

Enter assignee name

Santa Clara, CA, United States of America

Ilypsa, Inc.

USPTO Granted Patents = 12

EPO Patents = 2

Forward Citations = 267

Loading Chart...

Loading Chart...

21 inventors (with patents filed for the assignee):

Dominique Charmot (12 out of 113 patents)

Eric F Connor (9 out of 44 patents)

Han Ting Chang (9 out of 30 patents)

4. Florence Roger (9 out of 10 patents)

5. Jerry M Buysse (4 out of 27 patents)

6. Jun Shao (4 out of 13 patents)

7. Son Hoai Nguyen (4 out of 5 patents)

8. Michael James Cope (4 out of 26 patents)

9. Han-Ting Chang (3 out of 32 patents)

10. Angela Lee (3 out of 6 patents)

11. Deidre Madsen (3 out of 7 patents)

12. Jonathan Mills (3 out of 4 patents)

13. John Fordtran (3 out of 9 patents)

14. Gerrit Klaerner (2 out of 49 patents)

15. Samir Z Zard (2 out of 24 patents)

12 patents: Sort by Forward Citations

1. 8349305 - Crosslinked amine polymers (2013-01-08),

2. 7767768 - Crosslinked amine polymers (2010-08-03),

3. 7754199 - Pharmaceutical compositions comprising crosslinked amine polymer with repeat units derived from polymerization of tertiary amines (2010-07-13),

4. 7718746 - Anion-binding polymers and uses thereof (2010-05-18),

5. 7666898 - Multivalent indole compounds and use thereof as phospholipase-A2 inhibitors (2010-02-23),

6. 7608674 - Pharmaceutical compositions comprising cross-linked small molecule amine polymers (2009-10-27),

7. 7589238 - Treatment of hyperphosphatemia using crosslinked small molecule amine polymers (2009-09-15),

8. 7459502 - Pharmaceutical compositions comprising crosslinked polyamine polymers (2008-12-02),

9. 7449605 - Crosslinked amine polymers (2008-11-11),

10. 7385012 - Polyamine polymers (2008-06-10),

11. 7342083 - Polyamine polymers (2008-03-11),

12. 7335795 - Crosslinked amine polymers (2008-02-26),

Ilypsa, Inc. is a leading pharmaceutical company specializing in the development and commercialization of innovative kidney disease treatments. With a strong focus on research and development, Ilypsa is dedicated to improving the lives of patients suffering from renal conditions. Their advanced therapies aim to provide effective solutions for various kidney-related disorders. Through continuous innovation and a commitment to patient care, Ilypsa strives to make a significant impact in the field of nephrology.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 23 2025

12 Patents

#292 in Santa Clara, CA

#5,875 in California

#24,782 in US

#46,701 in the World

Santa Clara, CA, United States of America

Ilypsa, Inc.

Forward Citations = 267

21 inventors:

Dominique Charmot (12 out of 113 patents)

Eric F Connor (9 out of 44 patents)

Han Ting Chang (9 out of 30 patents)

4. Florence Roger (9 out of 10 patents)

5. Jerry M Buysse (4 out of 27 patents)

Please report any incorrect information to support@idiyas.com

Loading…